MYASTHAENIA GRAVIS
Clinical trials for MYASTHAENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new MYASTHAENIA GRAVIS trials appear
Sign up with your email to follow new studies for MYASTHAENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a One-Time cell therapy ease severe muscle weakness?
Disease control Recruiting nowThis phase 3 study tests an experimental therapy called Descartes-08 for adults with generalized myasthenia gravis, a condition causing muscle weakness. The treatment uses modified immune cells (mRNA CAR T-cells) to target the disease. About 100 participants will receive either t…
Matched conditions: MYASTHAENIA GRAVIS
Phase: PHASE3 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
15-Year safety check for experimental CAR t therapy begins
Knowledge-focused Recruiting nowThis study tracks 70 people who have already received an infusion of KYV-101, a CAR T cell therapy, for autoimmune diseases like lupus, multiple sclerosis, and rheumatoid arthritis. The goal is to watch for delayed side effects, new cancers, or other health problems over up to 15…
Matched conditions: MYASTHAENIA GRAVIS
Sponsor: Kyverna Therapeutics • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC